Similar changes in MMP7 levels have been observed in the lung epithelium of patients with IPF, suggesting that MMP7-targeted therapies may have a future in the treatment of human fibrotic disease. This evidence concerns the gene MMP7 and idiopathic pulmonary fibrosis.